Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Achieve Life Sciences Second Quarter 2025 Earnings Conference Call and Webcast. As a reminder, this conference is being recorded.
Achieve Life Sciences Inc. (ACHV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Propel Bio Management Leen Kawas And Richard Kayne | 6,153,091 | $13,905,986 | +151% | 16.88% |
| 2. | Alyeska Investment Group Anand Parekh | 3,504,333 | $7,919,793 | +733% | 0.03% |
| 3. | Clearline Capital Marc Majzner | 1,326,259 | $2,997,345 | 0.11% | |
| 4. | Hudson Bay Capital Management Sander Gerber | 1,173,532 | $2,652,182 | 0.01% | |
| 5. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 898,885 | $2,031,480 | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.89 | 10,000 | $28,887.00 | 10,000 | 2025-03-17 | Filing | |
| $2.86 | 10,000 | $28,598.00 | 60,876 | 2025-03-17 | Filing | |
| $4.59 | 10,000 | $45,850.00 | 38,501 | 2024-03-04 | Filing | |
| $4.59 | 10,000 | $45,850.00 | 76,724 | 2024-03-04 | Filing | |
| $5.50 | 5,000 | $27,500.00 | 66,730 | 2023-05-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | $0.00 | 796,594 | 2019-06-11 | Filing | |
| $2.85 | 44,982 | $128,198.70 | 796,594 | 2019-06-11 | Filing | |
| $0.00 | 0 | $0.00 | 841,576 | 2019-06-11 | Filing | |
| $3.01 | 2,200 | $6,622.00 | 841,576 | 2019-06-11 | Filing | |
| $0.00 | 0 | $0.00 | 843,776 | 2019-06-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,459,014 | $10,077,372 | 0% | |
| 2. | 2,149,877 | $4,858,722 | 0% | |
| 3. | 1,184,512 | $2,676,997 | 0.13% | |
| 4. | 989,509 | $2,236,290 | 0.6% | |
| 5. | 362,200 | $819,037 | 0% |
News See All
Should You Hold Achieve Life Sciences (ACHV)?
Rogue Funds, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund depreciated 12.4% net of fees in the quarter.
Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment
Omnicom Group Inc. (NYSE:OMC) is one of the best high short interest stocks with huge upside potential. On June 26, Achieve Life Sciences Inc.
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2025 Earnings Call Transcript
Operator: Greetings. Welcome to Achieve Life Sciences First Quarter 2025 Earnings Conference Call and Webcast. At this time all participants are in a listen-only mode.
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
We came across a bullish thesis on Achieve Life Sciences, Inc. (ACHV) on Substack by Rogue Funds. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Achieve Life Sciences Fourth Quarter and Year-End 2024 Earnings Call and Webcast. At this time all participants are in a listen-only mode.
Here are Rogue Funds Updates on Achieve Life Sciences (ACHV)
Rogue Funds, an investment management company, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.59% net of fees in the quarter.
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
We came across a bullish thesis on Achieve Life Sciences, Inc. (ACHV) on Substack by Jacob Rowe. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.
Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1?
Rogue Funds, an investment management company, released its third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -3.03% net of fees in the quarter.
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Achieve Life Sciences Third Quarter 2024 Earnings Conference Call and Webcast. [Operator Instructions] And as a reminder, this conference is being recorded.